Clinical Trial Update: The Effectiveness and Safety of Tenofovir Alafenamide in the Treatment of Chronic Hepatitis B Patients With Mildly Elevated Alanine Aminotransferase and Significant Liver Injury. [Phase 4]

View source ↗

Summary

Phase 4 trial updating on effectiveness and safety of tenofovir alafenamide in chronic hepatitis B patients with mildly elevated ALT and significant liver injur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Tenofovir alafenamide (tenofovir alafenamide)

Snippet

Sponsor: National Cheng-Kung University Hospital | Conditions: Chronic Hepatitis b | Phase 4 | Status: UNKNOWN